Skip to content

The application of a novel of Nasal Pharyngeal Set-flexible (NaPSflex)in deep sedation during endoscopic retrograde cholangiopancreatography in elderly patients: a prospective randomized controlled study

The application of a novel of Nasal Pharyngeal Set-flexible (NaPSflex)in deep sedation during endoscopic retrograde cholangiopancreatography in elderly patients: a prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117194
Enrollment
Unknown
Registered
2026-01-21
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreaticobiliary pathologies

Interventions

NaPSflex group:A disposable oxygen nasal catheter was used

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
80 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective ERCP, 2. Both sexes, aged >=80 years old, 3. American Society of Anesthesiologists (ASA) grade I-III, 4.BMI: 18-30kg/m2.

Exclusion criteria

Exclusion criteria: 1. Patients requiring tracheal intubation under general anesthesia, 2. Patients with obstructive sleep apnea syndrome, 3. Patients allergic to local anesthetics, 4. History of upper respiratory tract infection within 14 days, 5. History of nasal surgery or abnormal nasal structure, 6. Recent nasal and facial trauma, 7. History of skull base fracture, 8. Unwilling or unable to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Incidence of SpO2=92%;

Secondary

MeasureTime frame
Incidence of SpO2=95%;Incidence of SpO2=85%;Frequency of maneuvers to manage the decrease of SpO2;Satisfaction score of endoscopist;Satisfaction score of anesthesiologist;

Countries

China

Contacts

Public ContactWu Feixiang

The First Affiliated Hospital of Wenzhou Medical University

feixiangwu@hotmail.com+86 136 2170 2854

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026